Ollin Bio
Ollin Bio is a privately held biotechnology company developing novel therapeutics, organizing its work around defined therapeutic areas and a product pipeline of drug candidates in development. Backed by a16z, the company was added to the API Evangelist network as a portfolio-company lead. As a research-stage therapeutics company, Ollin Bio publishes a marketing and corporate website but does not expose a public developer program, API, documentation, or SDKs at this time. This profile records the company's public identity and web properties; it will be re-enriched if a public API surface ever appears.
Ollin Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Life Sciences, and Drug Development.
Kin Score
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| VC Portfolios (a16z, Battery Ventures, Sequoia Capital, Index Ventures participation) | standard | 17.2 (thin) | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.